Michael Franklin

Vice President-Clinical Central Services and Innovation

Lilly

An Innovative Integrator with the goal to drive Access to enable Clinical Trials to be a Health Care option while reducing the burden on the patient & Investigator all while accelerating the development of medicines to those in need.
Drug development expert with experience in:
• Decentralized Trials leader
• Taking the clinical trial to the patient
. Community based research and mobile research units
• Integrated Drug Development and Portfolio/Project Management
• Early and Late Phase Drug Development
• Decentralized Studies/Direct to Patient
• External Sponsor Research
• CMC Development, GXP Drug processes, Quality & Clinical Trial Material
• Global Logistics & Distribution, Supply & Demand Management, Outsourcing & Wholesaler Strategy

General: Clinical Trial Supply Chain, Decentralized Studies, Direct to Patient, Wholesaler Strategy, Comparator & Ancillary strategy, Business development (Mergers & Acquisitions), TransCelerate, Pharmaceutical Project & Portfolio Management, Expanded Access, Digital HealthClinical Trail Material Management, Covid Support, PreClinical through Phase 4 Drug Development experience, Clinical Trial Design and Execution, Comparator Sourcing, Business Acumen, Stategic staffing and Mentoring, Capacity planning, Critical Chain, Six Sigma, Alliance Management, Event management CAPA, RCA, trial material, Clinical Trial Design and Cost management, Leader Development

Scientific: Caliper/Agilent technology, Protein Purification, Chormatography, Crystallography, Tissue Culture and Cell expession, Mammalian & Baculovirus, Western, SDS-Page, FPLC, HPLC, Immunohistochemistry , GLP

Speaker Sessions